MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Long-term effects of a mobile technology-based brisk walking program on Parkinsonian symptoms in Parkinson’s disease – a randomized controlled trial

    MKY. Mak, ISK. Wong-Yu (Hong Kong SAR, China)

    Objective: To evaluate the effectiveness of a 6-month mobile technology-based brisk walking program on motor and non-motor symptoms and self-perceived ability in people with Parkinson’s…
  • 2023 International Congress

    Inferring Rigidity Scores in MDS-UPDRS Motor Assessment from Other Items

    F. Duque Quiceno, Y. Dushin, G. Sarapata, S. Komarov, A. Matveev, J. O'Keeffe (London, United Kingdom)

    Objective: This study aimed to explore the possibility of inferring rigidity scores in MDS-UPDRS assessments from other items to enhance the accuracy of clinical evaluations…
  • 2023 International Congress

    Impact of endpoint selection on sample size calculations for disease-modifying clinical trials in Parkinson’s disease patients with GBA1 mutations

    M. Fonseca, G. Castilla-Fernández, J. Liu, J. Holenz, N. Mendonça, D. Simon (Porto, Portugal)

    Objective: To assess clinical trial sample size estimations under variable simulated scenarios for Parkinson’s disease (PD) patients with mutations in the β-glucocerebrosidade gene (GBA1). Background:…
  • 2023 International Congress

    Parkinson’s disease and human gut microbiota in an Egyptian population: a pilot study

    S. Hashish, M. Hirose, A. Moustafa, A. Shalash, S. Ibrahim, M. Salama (Cairo, Egypt)

    Objective: The main objective of our research is to decipher the association between the gut microbiota and Parkinson's disease in an Egyptian cohort. Background: Parkinson’s…
  • 2023 International Congress

    PD.ai – Detection of Parkinson’s Disease with gait-based biomarkers using AI techniques

    SJS. Rajasekar, A. Stezin (Melmaruvathur, India)

    Objective: This study evaluated the utility of Artificial Intelligence (AI) in detection of patients with Parkinson’s disease from stride dynamics. Background: Parkinson’s Disease (PD) is…
  • 2023 International Congress

    Effects of cerebellar cTBS on motor symptoms in Huntington’s disease: a feasibility and pilot study

    JF. Martin Rodriguez, M. Gomez Crespo, FJ. Gómez Campos, AM. Castellano-Gerrero, V. Villarreal, FJ. Palomar Simón, P. Porcacchia, F. Carrillo, S. Jesús, P. Mir (Sevilla, Spain)

    Objective: To evaluate the feasibility and preliminary clinical effects of a single session of cerebellar cTBS in patients with Huntington's disease (HD) with mild-moderate motor…
  • 2023 International Congress

    Turning 360 degrees in standing – associations with perceived walking difficulties and comfortable gait speed in people with drug naïve/early Parkinson’s disease.

    MH. Nilsson, M. Lindh-Rengifo, E. Stomrud, O. Hansson, SB. Jonasson (Lund, Sweden)

    Objective: To investigate how turning performance (360 degrees in standing) is associated with perceived walking difficulties and comfortable gait speed in people with drug naïve…
  • 2023 International Congress

    Regional Atrophy and Motor Speech in PSP

    H. Clark, J. Stierwalt, F. Ali, H. Botha, K. Josephs, J. Whitwell (ROCHESTER, USA)

    Objective: This study examined the association of regional atrophy on MRI and motor speech in PSP. Background: Motor speech impairment is common in PSP[1]. Although…
  • 2023 International Congress

    Real-world effectiveness and safety of deutetrabenazine in patients with chorea associated with Huntington disease

    V. Sung, A. White, H. Romdhani, D. Goldschmidt, R. Ayyagari, N. Chaijale, A. Yaari, M. Gordon, J. Logan, A. Yang, R. Ribalov (Birmingham, USA)

    Objective: To assess real-world effectiveness and safety of deutetrabenazine (DTBZ) for chorea associated with Huntington disease (HD). Background: Real-world evidence on the impact of DTBZ…
  • 2023 International Congress

    Can radiofrequency lesion be better than DBS?

    J. Brainer, P. Brainer, A. Brainer, P. Brainer (Recife, Brazil)

    Objective: Pallidotomy represents a viable alternative for Parkinson disease(PD) symptoms treatment and has several important advantages, including a decreased need for access to specialists and clinical follow-up, improved affordability, and a lower infection risk, producing high long-term success rates and low morbidity rates. Background: Pallidotomy is recognized as effective for treating the symptoms of Parkinson's disease. Sometimes, radiofrequency may…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley